Dedifferentiated sacral chordoma: a case report

Hamdan, Asmah Hanim and Abd. Fuaat, Azliana and Ahmad Affandi, Khairunisa and Tuan Shariff, Sharifah Emilia (2021) Dedifferentiated sacral chordoma: a case report. In: 7th Annual Scientific Meeting 2021 (Virtual) , International Academy of Pathology Malaysia Division (IAPMD)., 5 - 7 October 2021, Kuantan, Pahang. (Unpublished)

	PDF (Poster presentation) - Presentation Restricted to Repository staff only Download (840kB) | Request a copy
	PDF (Acceptance letter) - Supplemental Material Restricted to Repository staff only Download (208kB) | Request a copy

Abstract

Chordoma is a rare bone sarcoma. It has a predilection for the axial skeleton. There are three recognized histologic variants of chordoma; conventional, dedifferentiated and poorly differentiated. This case report highlights the rarity of dedifferentiated chordoma pertaining to its morphology and immunohistochemical staining. Case report: A 58 years old lady, initially was diagnosed as sacral chordoma, however she defaulted her follow-up. Patient then presented again after several months with increasing size of the sacral mass associated with pain and neurologic symptoms. On examination, the tumour is 40x30cm extending from L4 to the gluteal fold. Magnetic Resonance Imaging (MRI) revealed the mass has significantly increased in size compared to previous MRI. Tumour resection was done. Histologically, the tumour cells are arranged as lobules composed of physaliphorous cells. In areas, there is abrupt transition between conventional chordoma and dedifferentiated component. The cells from conventional chordoma are positive for CKAE1/AE3, EMA and S100 while the same markers are negative in dedifferentiated component. Discussion: The dedifferentiated chordoma accounts for less than 5% of all chordomas. Most of the symptoms are neurologic. Histologically, the tumor contains areas of conventional chordoma and high-grade sarcomatous component, in which these areas being admixed and sharply demarcated. Immunohistochemically, positivity for CK, EMA, and S100 are traditionally used to support the diagnosis of a chordoma. This panel is generally sufficient to exclude differential diagnoses of chordoma eg: chondrosarcoma and metastatic renal cell carcinoma. Conclusion: Dedifferentiated chordoma differs from conventional chordoma by the rapid growth of tumor and its potential for distant metastasis.

Item Type:	Conference or Workshop Item (Poster)
Additional Information:	7751/93477 *Via online)
Uncontrolled Keywords:	primary bone tumor, chordoma, dedifferentiated chordoma
Subjects:	R Medicine > RB Pathology
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Pathology & Lab Medicine
Depositing User:	DR ASMAH HANIM HAMDAN
Date Deposited:	28 Dec 2021 09:51
Last Modified:	28 Dec 2021 09:51
URI:	http://irep.iium.edu.my/id/eprint/93477

Actions (login required)

View Item